ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 001,80
-0,48%
Dow Jones
38 798,99
-0,22%
DAX
18 557,27
-0,48%
Brent Oil
79,395
0,00%
Bitcoin
69 382,25
0,07%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Immunomedics Inc (IMMU)

  7. Immunomedics Inc (IMMU) Actualités

IMMU

Immunomedics (IMMU)

Immunomedics Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:IMMU
DateHeureSourceTitreSymboleSociété
16/02/202121h31Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:IMMUImmunomedics Inc
02/11/202014h27Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:IMMUImmunomedics Inc
30/10/202011h12Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:IMMUImmunomedics Inc
28/10/202000h22Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMMUImmunomedics Inc
26/10/202011h02Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:IMMUImmunomedics Inc
23/10/202023h26Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:IMMUImmunomedics Inc
23/10/202023h24Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:IMMUImmunomedics Inc
23/10/202014h51Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:IMMUImmunomedics Inc
23/10/202013h58Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:IMMUImmunomedics Inc
23/10/202013h50Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:IMMUImmunomedics Inc
12/10/202014h00GlobeNewswire Inc.Immunomedics Announces FDA Orphan Drug Designation of Trodelvy™ for Adult and Pediatric GlioblastomaNASDAQ:IMMUImmunomedics Inc
24/09/202014h10Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:IMMUImmunomedics Inc
24/09/202014h01Edgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:IMMUImmunomedics Inc
21/09/202012h02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IMMUImmunomedics Inc
19/09/202017h00GlobeNewswire Inc.Immunomedics Announces Positive Results from Pivotal Phase 2 TROPHY U-01 Study of Trodelvy™ in Metastatic Urothelial Cancer...NASDAQ:IMMUImmunomedics Inc
19/09/202016h30GlobeNewswire Inc.Trodelvy™ Significantly Extends Survival in Phase 3 ASCENT Study of Metastatic Triple-Negative Breast CancerNASDAQ:IMMUImmunomedics Inc
18/09/202014h00GlobeNewswire Inc.Immunomedics Announces Encouraging Early-Stage Clinical Results with Trodelvy™ in Brain CancersNASDAQ:IMMUImmunomedics Inc
16/09/202022h59Edgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:IMMUImmunomedics Inc
14/09/202023h14Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:IMMUImmunomedics Inc
14/09/202014h26Dow Jones NewsImmunomedics Shares More Than Double After Gilead DealNASDAQ:IMMUImmunomedics Inc
14/09/202009h02Dow Jones NewsGilead Acquires Cancer-Drug Maker -- WSJNASDAQ:IMMUImmunomedics Inc
14/09/202003h01Dow Jones NewsGilead Reaches Deal to Buy Immunomedics for $21 Billion -- 5th UpdateNASDAQ:IMMUImmunomedics Inc
13/09/202022h29Dow Jones NewsGilead Reaches Deal to Buy Immunomedics for $21 Billion--4th UpdateNASDAQ:IMMUImmunomedics Inc
13/09/202021h00Business WireGilead Sciences to Acquire ImmunomedicsNASDAQ:IMMUImmunomedics Inc
12/09/202022h01Dow Jones NewsGilead Nears Deal to Buy Immunomedics for More Than $20 Billion--3rd UpdateNASDAQ:IMMUImmunomedics Inc
12/09/202021h50Dow Jones NewsGilead Nears Deal to Buy Immunomedics for More Than $20 Billion--2nd UpdateNASDAQ:IMMUImmunomedics Inc
12/09/202021h39Dow Jones NewsGilead Nears Deal to Buy Immunomedics for More Than $20 Billion--UpdateNASDAQ:IMMUImmunomedics Inc
12/09/202021h22Dow Jones NewsGilead Nears Deal to Buy Immunomedics for More Than $20 BillionNASDAQ:IMMUImmunomedics Inc
09/09/202013h00GlobeNewswire Inc.Immunomedics Announces Key Oral Presentations at ESMO Virtual Congress 2020NASDAQ:IMMUImmunomedics Inc
02/09/202014h00GlobeNewswire Inc.Immunomedics to Participate in Upcoming Healthcare ConferencesNASDAQ:IMMUImmunomedics Inc
 Showing the most relevant articles for your search:NASDAQ:IMMU

Dernières Valeurs Consultées

EU
VIV
Vivendi
EU
AI
Air Liquide
NASDAQ
AMZN
Amazon.com
EU
ORA
Orange
EU
GLE
Societe Generale
NYSE
MRK
Merck
NYSE
KO
Coca Cola
EU
PX1
CAC 40
EU
SGO
Cie de SaintGobain
EU
MC
Lvmh Moet Hennessy Louis...
EU
LR
Legrand
NASDAQ
AAPL
Apple
EU
CS
Axa
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés